BMS-181174 is an analog of Mitomycin C with activity against a range of tumour cell lines and xenografts, including MMC-resistant tumours. Phase I clinical trials from Bristol-Myers Squibb demonstrated that BMS-181174 has a similar toxicity profile to mitomycin.
MedKoo Cat#: 574452
Name: BMS-181174
CAS#: 95056-36-3
Chemical Formula: C23H25N5O7S2
Exact Mass: 547.1195
Molecular Weight: 547.60
Elemental Analysis: C, 50.45; H, 4.60; N, 12.79; O, 20.45; S, 11.71
The following data is based on the product molecular weight 547.60 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
